Importantly, our data, derived from a polyparisitized set of samples, suggests that the reduction in GM-CSF levels is not driven by any of the co-occurring infectious diseases such as geohelminths, hepatitis or malaria. This evidence concerns the gene CSF2 and Hepatitis.